Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon∗)
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 71 (1) , 106-108
- https://doi.org/10.1016/s0015-0282(98)00408-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trialFertility and Sterility, 1998
- Ovulation induction: The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproductionHuman Reproduction, 1995
- Endocrinology: Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patientsHuman Reproduction, 1995
- Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patientsHuman Reproduction, 1994
- Simplifying in-vitro fertilization therapyCurrent Opinion in Obstetrics and Gynecology, 1994
- First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndromeHuman Reproduction, 1994
- Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndromeHuman Reproduction, 1991
- Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormoneFertility and Sterility, 1991